|
|
Last Modified: 3/30/2007  First Published: 8/1/2000 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III, Phase II
|
|
|
|
Prevention
|
|
|
|
Closed
|
|
|
|
18 and over
|
|
|
|
NCI
|
|
|
|
MDA-ID-99368 NCI-P00-0165, SC-NQ4-99-02-006, NCT00006124
|
|
|
|
|
|
|
|
Last Modified: 11/1/2006  First Published: 2/1/2002 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III, Phase II
|
|
|
|
Prevention
|
|
|
|
Closed
|
|
|
|
18 and over
|
|
|
|
NCI
|
|
|
|
UAB-9833 UAB-NQ401A4009, UAB-NQ49902009, NCI-P00-0161, NCI-P01-0197, NCT00027976
|
|
|
|
|
|
|
|
Last Modified: 6/12/2007  First Published: 4/1/2000 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Prevention
|
|
|
|
Closed
|
|
|
|
30 and over
|
|
|
|
NCI
|
|
|
|
BWH-NO1-CN-95015 NYH-CMC-0298-108, SC-IQ4-99-02-005, STRANG-98-008, NCI-P00-0141, NCT00005094
|
|
|
|
|
|
|
|
Last Modified: 12/12/2007  First Published: 6/23/2003 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
18 and over
|
|
|
|
Other
|
|
|
|
EORTC-40015 NCT00064181
|
|
|
|
|
|
|
|
Last Modified: 6/22/2006  First Published: 5/28/2004 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
18 and over
|
|
|
|
Other
|
|
|
|
EORTC-40023 PETACC-5, NCT00085163
|
|
|
|
|
|
|
|
Last Modified: 9/18/2006  First Published: 6/23/2004 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Prevention
|
|
|
|
Completed
|
|
|
|
18 and over
|
|
|
|
NCI
|
|
|
|
NSABP-P-3 NCT00087256
|
|
|
|
|
|
|
|
Last Modified: 4/11/2008  First Published: 10/21/2006 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Prevention
|
|
|
|
Completed
|
|
|
|
10 to 17
|
|
|
|
NCI
|
|
|
|
MDA-2006-0040 PFIZER-A3191193, N01-CN-05126-2, NCT00393016
|
|
|
|
|
|
|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Prevention
|
|
|
|
Completed
|
|
|
|
30 and over
|
|
|
|
Pharmaceutical / Industry
|
|
|
|
EQ4-00-02-018 A3191107, NCT00141193
|
|
|
|
|
|
|
|
Last Modified: 2/1/2001  First Published: 5/1/1998 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II, Phase I
|
|
|
|
Prevention
|
|
|
|
Closed
|
|
|
|
18 and over
|
|
|
|
NCI
|
|
|
|
NCI-98-C-0087
|
|
|
|
|
|
|
|
Last Modified: 3/3/2008  First Published: 9/1/2001 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II, Phase I
|
|
|
|
Treatment
|
|
|
|
Completed
|
|
|
|
18 to 85
|
|
|
|
NCI
|
|
|
|
RTOG-C-0128 NCT00023660
|
|
|
|